Notably, this study included broad range of GLP-1 drugs, including much older GLP-1s that have far lower anti-obesity, anti-craving, and anti-addictive effects: abiglutide (Eperzan, Tanzeum), dulaglutide (Trulicity), exenatide (Byetta, Bydureon), liraglutide (Victoza, Saxenda), lixisenatide (Adlyxin, Lyxumia), semaglutide (Ozempic, Rybelsus, Wegovy) and tirzepatide (Mounjaro) Its possible that the associations that were found would be even stronger if the study had looked exclusively at semaglutide and tirzepatide, which are the current best-in-class options for weight loss
We do, yes
Wegovy claims involving hospitalization, long-term gastroparesis, intestinal obstruction, persistent vomiting, malnutrition, future medical care, or permanent impairment may be valued differently than claims involving shorter-term symptoms
It's important to get in touch with your healthcare provider immediately if you experience any of the following: It's important to remember that not everyone who takes Semaglutide will experience these side effects
